MYRIAD GENETICS INC.

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

18 Jan 2024 17:10:00 By Nasdaq GlobeNewswire

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO

09 Jan 2024 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance

21 Dec 2023 07:30:00 By Nasdaq GlobeNewswire

Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care

20 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

20 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

16 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics to Participate in Stephens Annual Investment Conference

09 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock

08 Nov 2023 20:20:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock

08 Nov 2023 15:10:56 By Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance

06 Nov 2023 15:05:01 By Nasdaq GlobeNewswire

Myriad Genetics Appoints Sam Raha as Chief Operating Officer

01 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023

31 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

28 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

19 Sep 2023 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Issues 2022 Environmental, Social and Governance Report

19 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer

18 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

06 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

06 Sep 2023 06:00:00 By Nasdaq GlobeNewswire